Investment Summit

January 20, 2025 – Launch Day

An exclusive look into the dynamic investment landscape shaping the future of cell and gene therapies, whether you’re an investor seeking the next breakthrough or a biotech company aiming to secure funding, this summit provides the insights, strategies, and connections. Join top investors, industry leaders, and pioneering biotech firms for an in-depth exploration of the latest trends and opportunities in advanced therapy funding.

Key Takeaways from the Investment Summit:

Building on the success of our oversubscribed 2024 investment sessions, the 2025 Investment Summit will delve even deeper into critical topics that define the current biotech funding landscape. Through interactive discussions and workshops, you’ll gain actionable insights into:

  • Biotech Funding Trends in 2025: Discover where biotech funds are being directed, and which therapeutic areas are seeing the most attention from investors.
  • Investor Focus Areas: Learn what trends are driving investment decisions in 2025 and what factors are guiding strategic partnerships in cell and gene therapies.
  • Early-stage Biotech Project Criteria: Understand what investors are looking for in early-stage biotech projects and what makes a promising venture stand out.
  • Pitfalls to Avoid: Find out the red flags that make investors shy away and how to avoid common pitfalls that could hinder your pitch or project.
  • Pitching Your Science: Get insider tips on how to effectively present your biotech innovation to an investor audience and secure the funding needed to take your research to the next level. 

This is your opportunity to connect with the top minds in biotech investment, uncover new funding strategies, and gain a competitive edge in securing capital for your advanced therapy projects.

The full agenda will be announced soon—register now to be among the first to hear and secure your place!